Porphyrias at a glance

Diagnosis and treatment

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Porphyrias are a group of eight rare inherited metabolic disorders of heme biosynthesis pathway. Porphyrias are still underdiagnosed, although examinations of urine and plasma are first-line tests for detecting excess of porphyrins or heme precursors in suspected patients. Diagnosis, particularly for the acute forms, is essential to avoid precipitating factors and the use of triggering drugs. Mutation screening of family members is recommended to identify presymptomatic carriers and to prevent acute attacks. The therapeutic approach should be appropriate regarding specific forms of porphyria and treatment should be started promptly.

Original languageEnglish
Pages (from-to)73-80
Number of pages8
JournalInternal and Emergency Medicine
Volume5
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 2010

Fingerprint

Porphyrias
Heme
Precipitating Factors
Porphyrins
Therapeutics
Urine
Mutation
Pharmaceutical Preparations

Keywords

  • ALA
  • Heme
  • Porphobilinogen
  • Porphyrias
  • Porphyrins

ASJC Scopus subject areas

  • Emergency Medicine
  • Internal Medicine

Cite this

Porphyrias at a glance : Diagnosis and treatment. / Cappellini, Maria Domenica; Brancaleoni, Valentina; Graziadei, Giovanna; Tavazzi, Dario; Di Pierro, Elena.

In: Internal and Emergency Medicine, Vol. 5, No. SUPPL. 1, 2010, p. 73-80.

Research output: Contribution to journalArticle

@article{4bb855648fa541af97c7931b6cf39401,
title = "Porphyrias at a glance: Diagnosis and treatment",
abstract = "Porphyrias are a group of eight rare inherited metabolic disorders of heme biosynthesis pathway. Porphyrias are still underdiagnosed, although examinations of urine and plasma are first-line tests for detecting excess of porphyrins or heme precursors in suspected patients. Diagnosis, particularly for the acute forms, is essential to avoid precipitating factors and the use of triggering drugs. Mutation screening of family members is recommended to identify presymptomatic carriers and to prevent acute attacks. The therapeutic approach should be appropriate regarding specific forms of porphyria and treatment should be started promptly.",
keywords = "ALA, Heme, Porphobilinogen, Porphyrias, Porphyrins",
author = "Cappellini, {Maria Domenica} and Valentina Brancaleoni and Giovanna Graziadei and Dario Tavazzi and {Di Pierro}, Elena",
year = "2010",
doi = "10.1007/s11739-010-0449-7",
language = "English",
volume = "5",
pages = "73--80",
journal = "Internal and Emergency Medicine",
issn = "1828-0447",
publisher = "Springer-Verlag Italia s.r.l.",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Porphyrias at a glance

T2 - Diagnosis and treatment

AU - Cappellini, Maria Domenica

AU - Brancaleoni, Valentina

AU - Graziadei, Giovanna

AU - Tavazzi, Dario

AU - Di Pierro, Elena

PY - 2010

Y1 - 2010

N2 - Porphyrias are a group of eight rare inherited metabolic disorders of heme biosynthesis pathway. Porphyrias are still underdiagnosed, although examinations of urine and plasma are first-line tests for detecting excess of porphyrins or heme precursors in suspected patients. Diagnosis, particularly for the acute forms, is essential to avoid precipitating factors and the use of triggering drugs. Mutation screening of family members is recommended to identify presymptomatic carriers and to prevent acute attacks. The therapeutic approach should be appropriate regarding specific forms of porphyria and treatment should be started promptly.

AB - Porphyrias are a group of eight rare inherited metabolic disorders of heme biosynthesis pathway. Porphyrias are still underdiagnosed, although examinations of urine and plasma are first-line tests for detecting excess of porphyrins or heme precursors in suspected patients. Diagnosis, particularly for the acute forms, is essential to avoid precipitating factors and the use of triggering drugs. Mutation screening of family members is recommended to identify presymptomatic carriers and to prevent acute attacks. The therapeutic approach should be appropriate regarding specific forms of porphyria and treatment should be started promptly.

KW - ALA

KW - Heme

KW - Porphobilinogen

KW - Porphyrias

KW - Porphyrins

UR - http://www.scopus.com/inward/record.url?scp=77957143219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957143219&partnerID=8YFLogxK

U2 - 10.1007/s11739-010-0449-7

DO - 10.1007/s11739-010-0449-7

M3 - Article

VL - 5

SP - 73

EP - 80

JO - Internal and Emergency Medicine

JF - Internal and Emergency Medicine

SN - 1828-0447

IS - SUPPL. 1

ER -